EJEdward C. Jones-Lopez

Edward C. Jones-Lopez

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Edward C. Jones-Lopez has a total of 433 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Unexpected detection of Mycobacterium tuberculosis DNA in US-born patients in putative association with clinical syndromes

    by Edward C. Jones-López, Nancy S. Miller, Beverley Orr, Laura F. White, Solange Vinhas, Moses Mpeirwe, Patrick Orikiriza, Juliet Mwanga-Amumpaire, Moises Palaci, Reynaldo Dietze, et al.

    Sequential inflammatory stages characterizing early tuberculosis (TB) disease and reports of differentially culturable M. tuberculosis have compounded existing gaps in the detection of paucibacillary TB disease, threatening global elimination goals. Here we report unanticipated results we encountered while conducting early development work for an ultrasensitive molecular TB assay that has been validated in various cohorts of patients with suspected TB disease. Detection of M. tuberculosis DNA (TB-DNA) was confirmed by an alternate molecular target and sequencing. Over a six-year period, we conducted three separate clinical studies (N = 297) that tested two sets of anonymized respiratory samples from patients hospitalized in two Boston hospitals, and a longitudinal observational study to determine clinical associations and outcomes. We found an unexpectedly high prevalence of TB-DNA in US-born patients and a potential association with acute chest syndrome in patients with sickle cell disease. These results are preliminary and will require further study in prospective studies that include clinical, radiological, immunological, and microbiological correlation.

  • Open Access

    Using Cure Models to Estimate the Serial Interval of Tuberculosis With Limited Follow-up

    by Yicheng Ma, Helen E Jenkins, Paola Sebastiani, Jerrold J Ellner, Edward C Jones-López, Reynaldo Dietze, Jr. Charles R Horsburgh, Laura F White

    Serial interval (SI), defined as the time between symptom onset in an infector and infectee pair, is commonly used to understand infectious diseases transmission. Slow progression to active disease, as well as the small percentage of individuals who will eventually develop active disease, complicate the estimation of the SI for tuberculosis (TB). In this paper, we showed via simulation studies that when there is credible information on the percentage of those who will develop TB disease following infection, a cure model, first introduced by Boag in 1949, should be used to estimate the SI for TB. This model includes a parameter in the likelihood function to account for the study population being composed of those who will have the event of interest and those who will never have the event. We estimated the SI for TB to be approximately 0.5 years for the United States and Canada (January 2002 to December 2006) and approximately 2.0 years for Brazil (March 2008 to June 2012), which might imply a higher occurrence of reinfection TB in a developing country like Brazil.


  • Open Access

    Mycobacterium tuberculosis progresses through two phases of latent infection in humans

    by Roberto Colangeli, Aditi Gupta, Solange Alves Vinhas, Uma Deepthi Chippada Venkata, Soyeon Kim, Courtney Grady, Edward C. Jones-López, Patricia Soteropoulos, Moisés Palaci, Patrícia Marques-Rodrigues, et al.

    Little is known about the physiology of latent Mycobacterium tuberculosis infection. We studied the mutational rates of 24 index tuberculosis (TB) cases and their latently infected household contacts who developed active TB up to 5.25 years later, as an indication of bacterial physiological state and possible generation times during latent TB infection in humans. Here we report that the rate of new mutations in the M. tuberculosis genome decline dramatically after two years of latent infection (two-sided p < 0.001, assuming an 18 h generation time equal to log phase M. tuberculosis, with latency period modeled as a continuous variable). Alternatively, assuming a fixed mutation rate, the generation time increases over the latency duration. Mutations indicative of oxidative stress do not increase with increasing latency duration suggesting a lack of host or bacterial derived mutational stress. These results suggest that M. tuberculosis enters a quiescent state during latency, decreasing the risk for mutational drug resistance and increasing generation time, but potentially increasing bacterial tolerance to drugs that target actively growing bacteria.


  • Top Cited Papers

    Myelin Oligodendrocyte Glycoprotein Antibody–Associated Optic Neuritis and Myelitis in COVID-19

    by Siwei Zhou, Edward C. Jones-Lopez, Deepak J. Soneji, Christina J. Azevedo, Vivek R Md Patel

    An abstract is unavailable. This article is available as a PDF only.


  • Top Cited Papers

    The risk of tuberculosis in children after close exposure: a systematic review and individual-participant meta-analysis

    by Leonardo Martinez, Olivia Cords, C Robert Horsburgh, Jason R Andrews, Carlos Acuna-Villaorduna, Shama Desai Ahuja, Neus Altet, Orvalho Augusto, Davit Baliashvili, Sanjay Basu, et al.


  • Open Access

    Microbial Aerosols

    by Kevin P. Fennelly, Carlos Acuna-Villaorduna, Edward Jones-Lopez, William G. Lindsley, Donald K. Milton


  • Open Access

    Cross-validation of existing signatures and derivation of a novel 29-gene transcriptomic signature predictive of progression to TB in a Brazilian cohort of household contacts of pulmonary TB

    by Samantha Leong, Yue Zhao, Rodrigo Ribeiro-Rodrigues, Edward C. Jones-López, Carlos Acuña-Villaorduña, Patricia Marques Rodrigues, Moises Palaci, David Alland, Reynaldo Dietze, Jerrold J. Ellner, et al.


  • Open Access

    Partitioning the risk of tuberculosis transmission in household contact studies

    by Avery I. McIntosh, Helen E. Jenkins, C. Robert Horsburgh, Edward C. Jones-López, Christopher C. Whalen, Mary Gaeddert, Patricia Marques-Rodrigues, Jerrold J. Ellner, Reynaldo Dietze, Laura F. White

    Household contact studies of tuberculosis (TB) are a common way to study disease transmission dynamics. However these studies lack a mechanism for accounting for community transmission, which is known to be significant, particularly in high burden settings. We illustrate a statistical approach for estimating both the correlates with transmission of TB in a household setting and the probability of community transmission using a modified Bayesian mixed-effects model. This is applied to two household contact studies in Vitória, Brazil from 2008–2013 and Kampala, Uganda from 1995–2004 that enrolled households with an individual that was recently diagnosed with pulmonary TB. We estimate the probability of community transmission to be higher in Uganda (ranging from 0.21 to 0.69, depending on HHC age and HIV status of the index case) than in Brazil (ranging from 0.13 for young children to 0.50 in adults). These estimates are consistent with a higher overall burden of disease in Uganda compared to Brazil. Our method also estimates an increasing risk of community-acquired TB with age of the household contact, consistent with existing literature. This approach is a useful way to integrate the role of the community in understanding TB disease transmission dynamics in household contact studies.


  • Further evidence of Mycobacterium tuberculosis in the sputum of culture-negative pulmonary tuberculosis suspects using an ultrasensitive molecular assay

    by Guillermo Madico, Solange Vinhas, Beverley Orr, Laura White, Mary Gaeddert, Nancy S. Miller, Moses Mpeirwe, Patrick Orikiriza, Juliet Mwanga-Amumpaire, Yap Boum, et al.


  • Open Access

    Host Determinants of Infectiousness in Smear-Positive Patients With Pulmonary Tuberculosis

    by Carlos Acuña-Villaorduña, Irene Ayakaka, Luiz Guilherme Schmidt-Castellani, Francis Mumbowa, Patricia Marques-Rodrigues, Mary Gaeddert, Laura F White, Moises Palaci, Jerrold J Ellner, Reynaldo Dietze, et al.

    Epidemiologic data suggests that only a minority of tuberculosis (TB) patients are infectious. Cough aerosol sampling is a novel quantitative method to measure TB infectiousness. We analyzed data from three studies conducted in Uganda and Brazil over a 13-year period. We included sputum acid fast bacilli (AFB) and culture positive pulmonary TB patients and used a cough aerosol sampling system (CASS) to measure the number of colony-forming units (CFU) of Mycobacterium tuberculosis in cough-generated aerosols as a measure for infectiousness. Aerosol data was categorized as: aerosol negative (CFU = 0) and aerosol positive (CFU > 0). Logistic regression models were built to identify factors associated with aerosol positivity. M. tuberculosis was isolated by culture from cough aerosols in 100/233 (43%) TB patients. In an unadjusted analysis, aerosol positivity was associated with fewer days of antituberculous therapy before CASS sampling (p = .0001), higher sputum AFB smear grade (p = .01), shorter days to positivity in liquid culture media (p = .02), and larger sputum volume (p = .03). In an adjusted analysis, only fewer days of TB treatment (OR 1.47 per 1 day of therapy, 95% CI 1.16-1.89; p = .001) was associated with aerosol positivity. Cough generated aerosols containing viable M. tuberculosis, the infectious moiety in TB, are detected in a minority of TB patients and rapidly become non-culturable after initiation of antituberculous treatment. Mechanistic studies are needed to further elucidate these findings.